Uppsala, Sweden-If use of sentinel node detection in bladder cancer provesas successful as recent studies suggest, it will not be long before moleculartests on the sentinel tissues replace full histologic reports in stagingthis disease. That's the prediction of Dan Theodorescu, MD, PhD, who hasbeen at work on a genetic-based cancer-detection test, but who thinks workthis year by a group in Sweden may portend a significant diagnostic toolfor bladder cancer: sentinel node analysis.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.